BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 28778337)

  • 1. Laser therapy for the genitourinary syndrome of menopause. A systematic review and meta-analysis.
    Pitsouni E; Grigoriadis T; Falagas ME; Salvatore S; Athanasiou S
    Maturitas; 2017 Sep; 103():78-88. PubMed ID: 28778337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
    Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CO2-Laser therapy and Genitourinary Syndrome of Menopause: A Systematic Review and Meta-Analysis.
    Filippini M; Porcari I; Ruffolo AF; Casiraghi A; Farinelli M; Uccella S; Franchi M; Candiani M; Salvatore S
    J Sex Med; 2022 Mar; 19(3):452-470. PubMed ID: 35101378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
    Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
    Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Laser Therapy for the Treatment of Genitourinary Syndrome of Menopause: A Protocol for Systematic Review and Meta-Analysis of Clinical Trials.
    Pessoa LLMN; Sarmento ACA; Medeiros KS; Costa APF; Gonçalves AK; Cobucci RN
    Front Reprod Health; 2021; 3():772690. PubMed ID: 36304041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbon dioxide laser therapy for the management of genitourinary syndrome of menopause: A meta‑analysis of randomized controlled trials.
    Ni Y; Lian J
    Exp Ther Med; 2024 Jan; 27(1):10. PubMed ID: 38223331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Falagas M; Tsiveleka A; Salvatore S; Athanasiou S
    Lasers Med Sci; 2017 Nov; 32(8):1865-1872. PubMed ID: 28770400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation on prevalence and risk factors associated with genitourinary syndrome of menopause in middle-aged and older women in Beijing community: a cross sectional study.
    Zhu Y; Wei J; Yang X; Zhu W; Zhang W
    BMC Womens Health; 2022 Dec; 22(1):558. PubMed ID: 36585649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CO
    Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S
    Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical methods for the treatment of genitourinary syndrome of menopause: A systematic review.
    Sarmento ACA; Lírio JF; Medeiros KS; Marconi C; Costa APF; Crispim JC; Gonçalves AK
    Int J Gynaecol Obstet; 2021 May; 153(2):200-219. PubMed ID: 33354773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CO
    Athanasiou S; Pitsouni E; Falagas ME; Salvatore S; Grigoriadis T
    Maturitas; 2017 Oct; 104():24-28. PubMed ID: 28923173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO
    Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M
    Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of vaginal therapies alternative to vaginal estrogens on sexual function and orgasm of menopausal women: A systematic review and meta-analysis of randomized controlled trials.
    Pitsouni E; Grigoriadis T; Douskos A; Kyriakidou M; Falagas ME; Athanasiou S
    Eur J Obstet Gynecol Reprod Biol; 2018 Oct; 229():45-56. PubMed ID: 30103082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of current therapies for genitourinary syndrome of menopause: A Bayesian network analysis of 29 randomized trials and 8311 patients.
    Li B; Duan H; Chang Y; Wang S
    Pharmacol Res; 2021 Feb; 164():105360. PubMed ID: 33307219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Jha S; Wyld L; Krishnaswamy PH
    Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the Time of Onset of Urinary Symptoms Affect Microablative Fractional CO
    Ruffolo AF; Casiraghi A; Marotta E; Degliuomini R; Parma M; Athanasiou S; Benini V; Candiani M; Salvatore S
    Lasers Surg Med; 2021 Sep; 53(7):953-959. PubMed ID: 33476052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravaginal energy-based devices and sexual health of female cancer survivors: a systematic review and meta-analysis.
    Athanasiou S; Pitsouni E; Douskos A; Salvatore S; Loutradis D; Grigoriadis T
    Lasers Med Sci; 2020 Feb; 35(1):1-11. PubMed ID: 31396795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Cervigni M
    Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.